SCHEMBL1978399

SCHEMBL1978399

Cc1ccc(C(N)=O)c(-c2cc3cnnc(-c4ccc(F)cc4F)c3n(C)c2=O)c1

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 20/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1311772 0.83 MAPK14 (1.00) MAPK14
SCHEMBL1311125 0.79 MAPK14 (0.66) MAPK14
SCHEMBL10286418 0.77 MAPK14 (0.71) MAPK14
SCHEMBL1311225 0.76 MAPK14 (1.00) MAPK14
SCHEMBL1311100 0.76 MAPK14 (0.72) MAPK14
SCHEMBL9103827 0.76 MAPK14 (0.79) MAPK14
SCHEMBL1978402 0.76 MAPK14 (0.67) MAPK14
SCHEMBL1311852 0.76 MAPK14 (0.70) MAPK14
SCHEMBL1312274 0.75 MAPK14 (0.75) MAPK14
SCHEMBL1311371 0.74 MAPK14 (1.00) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334674-A1 PYRIDAZINO- PYRIDINONE COMPOUNDS FOR THE TREATMENT OF PROTEIN KINASE MEDIATED DISEASES. Amgen, Inc (US) 2011-06-22 EP disclosed
WO-2010025201-A1 PYRIDAZINO- PYRIDINONE COMPOUNDS FOR THE TREATMENT OF PROTEIN KINASE MEDIATED DISEASES. AMGEN INC. (US) 2010-03-04 WO disclosed